- Active not recruitingPHASE2
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
This study looks at new drug combinations to treat prostate cancer that has spread and is no longer responding to standard hormone therapy. Researchers want to see how safe and effective these new combinations are and how the body handles them.
For: Prostatic Neoplasms, Castration-ResistantUnited States · Belgium · Canada - RecruitingPHASE1, PHASE2
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
This study is looking at new ways to treat advanced prostate cancer that has spread and medicines like hormone therapy no longer work. Researchers are testing the drug pembrolizumab, sometimes with other treatments, to see if it's safe and effective, aiming to find better options for patients.
For: Metastatic Castration-Resistant Prostate CancerUnited States · Australia · Canada